SlideShare a Scribd company logo
1 of 13
Noida Institute of Engineering and Technology (Pharmacy Institute)
Greater Noida
AN AUTONOMUS INSTITUTE
TOXICOKINETICS & SATURATION KINETICS
Presented by:-
Shilajit Das(2nd Sem)
M . Pharm (Pharmacology)
Submitted to:-
Dr . Saumya Das
Associate Professor
NIET(Pharmacy Institute)
Greater Noida
Introduction
• Toxicokinetics is defined as the generation of
pharmacokinetics data to design, conduct &
Interpretation of drug safety evaluation studies.
• In these studies, a minimum of two animal species
are employed, as per regulation of FDA.
1. Rodents(rat and mice )
2. Non-rodents(dogs)
2
Need of toxicokinetic Studies
• Generation of kinetic data for systemic exposure and
toxicity assessment of the drug.
• Safety/risk ratio
• Important in drug development stages especially in
preclinical stage.
• Useful for the setting safe dose level in clinical phases.
3
Objectives
To describe the systemic exposure achieved in
animals and its relationship to dose level and time
course of the toxicity study.
To relate the exposure achieved in toxicity studies to
toxicological findings and contribute to assessment of
human safety clinically.
To provide information which, in conjunction with the
toxicity findings contributes to the design of
subsequent non- clinical toxicity studies.
4
Toxicokinetic study goals
A. Pretoxicology study
• Recommend selection of species
• Route selection
• Develop data for dose selection
B. Toxicology study
• Provide estimate of internal dose
• Determine effects of age and
multiple
• Exposure on kinetics
General principles of TK studies
A. Quantification of exposure
B. Justification of time points for sampling
C. Dose level toxicity testing
D. Ratifying factor
E. Route of administration
F. Determination of metabolites
G. Statistical evaluation of data
H. Analytical methods
I. Reporting
6
Protocol for toxicokinetic validation
7
Rational
Selection of animal
Preliminary study
Chronic study
Main study
Methods of Evaluation
Statistical Analysis
Results of Reporting
Applications of toxicokinetic studies
 TK evaluation is useful in selection of
 Dose
 Dosing of form
 alternative dosing route
 evaluation of toxicological mechanism
 use for the setting safe dose level in clinical phase
 TK studies also used to reduces the animal number.
 TK evaluation is very important in drug development phase in both regulatory
and scientific perspective
 TK data are practically used for the purpose of drug discovery such as lead
optimization and candidate- selection
8
Drugs monitored for its toxicity
9
Saturation Kinetics
10
 Also known as nonlinear pharmacokinetics.
 The rate of process of a drug’s ADME are
dependent upon carrier or enzymes that are
substrate- specific.
 Have definite capacities and susceptible to
saturation high drug concentration.
 In such cases an essentially first- order kinetics
transform into a mixture of first- order and zero-
order rate processes and PK parameters change
with size of the administered dose.
Detection of non-linearity In pharmacokinetics
Determine of steady state plasma concentration at different
doses
Determine of some important PK parameters such as
Fraction bioavailability
Elimination half life or total systemic clearance
Reference
12
• Barton, H.A.., et al.(2006) . Application of saturation , Metabolism and
Excretion(ADME)data in Agriculture chemical . Critical Revies in
Toxicology.36:9-35
• OECD Guideline for testing of chemical:- 428 “Skin Absorption : in vitro
method ”(Adopted 13 April 2004)
• Gingrich, J., Pu Y., Ehrhardt, R ., Karthik raj , R., Kannan
• Brahmankar ,D.M. and Jaiswal , S. B.(2009) Biopharmaceutics and
Pharmacokinetics, Delhi
THANK YOU

More Related Content

Similar to presentation.pptx

Bioanlytical method development
Bioanlytical method developmentBioanlytical method development
Bioanlytical method developmentSagar Savale
 
Special concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalenceSpecial concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalencePradnya Shirude
 
THERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYTHERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYsopi_1234
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryProf. Dr. Basavaraj Nanjwade
 
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...AMIT KUMAR
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALTMU
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringlavanya nalluri
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsSwaroopaNallabariki
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltriallillibabu
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoverySuhas Reddy C
 
toxicokinetics-1.pptx
toxicokinetics-1.pptxtoxicokinetics-1.pptx
toxicokinetics-1.pptxUnnatikhare1
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Safety pharmacology by tasnim
Safety pharmacology by tasnimSafety pharmacology by tasnim
Safety pharmacology by tasnimTasnim Taher
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSanthanakumar21
 

Similar to presentation.pptx (20)

Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Bioanlytical method development
Bioanlytical method developmentBioanlytical method development
Bioanlytical method development
 
Special concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalenceSpecial concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalence
 
THERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYTHERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEY
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
 
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
Ich (s5 r2) The International Council for Harmonisationof Technical Requireme...
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
Safety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7ASafety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7A
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Toxikokinetics
ToxikokineticsToxikokinetics
Toxikokinetics
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animals
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltrial
 
ICH Safety Guidelines
ICH Safety GuidelinesICH Safety Guidelines
ICH Safety Guidelines
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
toxicokinetics-1.pptx
toxicokinetics-1.pptxtoxicokinetics-1.pptx
toxicokinetics-1.pptx
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Safety pharmacology by tasnim
Safety pharmacology by tasnimSafety pharmacology by tasnim
Safety pharmacology by tasnim
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptx
 
Dose selection
Dose selectionDose selection
Dose selection
 
Drug development process
Drug development processDrug development process
Drug development process
 

Recently uploaded

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 

Recently uploaded (20)

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 

presentation.pptx

  • 1. Noida Institute of Engineering and Technology (Pharmacy Institute) Greater Noida AN AUTONOMUS INSTITUTE TOXICOKINETICS & SATURATION KINETICS Presented by:- Shilajit Das(2nd Sem) M . Pharm (Pharmacology) Submitted to:- Dr . Saumya Das Associate Professor NIET(Pharmacy Institute) Greater Noida
  • 2. Introduction • Toxicokinetics is defined as the generation of pharmacokinetics data to design, conduct & Interpretation of drug safety evaluation studies. • In these studies, a minimum of two animal species are employed, as per regulation of FDA. 1. Rodents(rat and mice ) 2. Non-rodents(dogs) 2
  • 3. Need of toxicokinetic Studies • Generation of kinetic data for systemic exposure and toxicity assessment of the drug. • Safety/risk ratio • Important in drug development stages especially in preclinical stage. • Useful for the setting safe dose level in clinical phases. 3
  • 4. Objectives To describe the systemic exposure achieved in animals and its relationship to dose level and time course of the toxicity study. To relate the exposure achieved in toxicity studies to toxicological findings and contribute to assessment of human safety clinically. To provide information which, in conjunction with the toxicity findings contributes to the design of subsequent non- clinical toxicity studies. 4
  • 5. Toxicokinetic study goals A. Pretoxicology study • Recommend selection of species • Route selection • Develop data for dose selection B. Toxicology study • Provide estimate of internal dose • Determine effects of age and multiple • Exposure on kinetics
  • 6. General principles of TK studies A. Quantification of exposure B. Justification of time points for sampling C. Dose level toxicity testing D. Ratifying factor E. Route of administration F. Determination of metabolites G. Statistical evaluation of data H. Analytical methods I. Reporting 6
  • 7. Protocol for toxicokinetic validation 7 Rational Selection of animal Preliminary study Chronic study Main study Methods of Evaluation Statistical Analysis Results of Reporting
  • 8. Applications of toxicokinetic studies  TK evaluation is useful in selection of  Dose  Dosing of form  alternative dosing route  evaluation of toxicological mechanism  use for the setting safe dose level in clinical phase  TK studies also used to reduces the animal number.  TK evaluation is very important in drug development phase in both regulatory and scientific perspective  TK data are practically used for the purpose of drug discovery such as lead optimization and candidate- selection 8
  • 9. Drugs monitored for its toxicity 9
  • 10. Saturation Kinetics 10  Also known as nonlinear pharmacokinetics.  The rate of process of a drug’s ADME are dependent upon carrier or enzymes that are substrate- specific.  Have definite capacities and susceptible to saturation high drug concentration.  In such cases an essentially first- order kinetics transform into a mixture of first- order and zero- order rate processes and PK parameters change with size of the administered dose.
  • 11. Detection of non-linearity In pharmacokinetics Determine of steady state plasma concentration at different doses Determine of some important PK parameters such as Fraction bioavailability Elimination half life or total systemic clearance
  • 12. Reference 12 • Barton, H.A.., et al.(2006) . Application of saturation , Metabolism and Excretion(ADME)data in Agriculture chemical . Critical Revies in Toxicology.36:9-35 • OECD Guideline for testing of chemical:- 428 “Skin Absorption : in vitro method ”(Adopted 13 April 2004) • Gingrich, J., Pu Y., Ehrhardt, R ., Karthik raj , R., Kannan • Brahmankar ,D.M. and Jaiswal , S. B.(2009) Biopharmaceutics and Pharmacokinetics, Delhi